Prot #M19-044: A Phase 3, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Efficacy, Safety, and Tolerability of Upadacitinib in Adult and Adolescent Subjects with Non-Segmental Vitiligo Who Are Eligible for Systemic Therapy

Project: Research project

Status	Active
Effective start/end date	6/27/24 → 6/27/27

Project Details